17-47290971-A-T
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP7BP4BA1
This summary comes from the ClinGen Evidence Repository: The c.1143A>T (p.Val381=) variant is a synonymous variant that is not predicted by SpliceAI to impact splicing. In addition, it occurs at a nucleotide that is not conserved as shown by phyloP score of -0.329 (BP7). The computational predictor REVEL predicts no damaging effect on ITGB3 function (BP4). The highest population minor allele frequency in gnomAD v2.1.1 is 0.006167 (123/19946 alleles) in the East Asian population, which is higher than the ClinGen PD VCEP threshold (>0.0024) for BA1, and therefore meets this criterion (BA1). In summary, this variant meets the criteria to be classified as Benign for autosomal recessive Glanzmann Thrombasthenia based on the ACMG/AMP criteria applied, as specified by the ClinGen PD VCEP: BP7, BP4 and BA1 (VCEP specifications version 2). LINK:https://erepo.genome.network/evrepo/ui/classification/CA8623176/MONDO:0100326/011
Frequency
Consequence
NM_000212.3 synonymous
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -10 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ITGB3 | NM_000212.3 | c.1143A>T | p.Val381Val | synonymous_variant | Exon 9 of 15 | ENST00000559488.7 | NP_000203.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ITGB3 | ENST00000559488.7 | c.1143A>T | p.Val381Val | synonymous_variant | Exon 9 of 15 | 1 | NM_000212.3 | ENSP00000452786.2 | ||
| ENSG00000259753 | ENST00000560629.1 | n.1107A>T | non_coding_transcript_exon_variant | Exon 9 of 18 | 2 | ENSP00000456711.2 |
Frequencies
GnomAD3 genomes AF: 0.000217 AC: 33AN: 151950Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.000481 AC: 121AN: 251452 AF XY: 0.000456 show subpopulations
GnomAD4 exome AF: 0.000116 AC: 170AN: 1461776Hom.: 1 Cov.: 38 AF XY: 0.000110 AC XY: 80AN XY: 727202 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000224 AC: 34AN: 152068Hom.: 0 Cov.: 31 AF XY: 0.000215 AC XY: 16AN XY: 74348 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Glanzmann thrombasthenia Benign:2
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -
The c.1143A>T (p.Val381=) variant is a synonymous variant that is not predicted by SpliceAI to impact splicing. In addition, it occurs at a nucleotide that is not conserved as shown by phyloP score of -0.329 (BP7). The computational predictor REVEL predicts no damaging effect on ITGB3 function (BP4). The highest population minor allele frequency in gnomAD v2.1.1 is 0.006167 (123/19946 alleles) in the East Asian population, which is higher than the ClinGen PD VCEP threshold (>0.0024) for BA1, and therefore meets this criterion (BA1). In summary, this variant meets the criteria to be classified as Benign for autosomal recessive Glanzmann Thrombasthenia based on the ACMG/AMP criteria applied, as specified by the ClinGen PD VCEP: BP7, BP4 and BA1 (VCEP specifications version 2). -
ITGB3-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
not provided Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at